Review



braf exon15 c 1799t a p v600e  (Geneseeq Technology Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Geneseeq Technology Inc braf exon15 c 1799t a p v600e
    Imaging features of adult metanephric stromal tumor with BRAF <t>V600E</t> mutation. (A) Computed tomography scan shows a slightly enhanced, well-defined, oval mass (white arrow), in the upper pole of the left kidney. (B) Magnetic resonance imaging demonstrates that the mass has low-signal intensity on T2-wighted imaging (white arrow).
    Braf Exon15 C 1799t A P V600e, supplied by Geneseeq Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/braf exon15 c 1799t a p v600e/product/Geneseeq Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    braf exon15 c 1799t a p v600e - by Bioz Stars, 2025-01
    86/100 stars

    Images

    1) Product Images from "Metanephric stromal tumor with BRAF V600E mutation in an adult patient: Case report and literature review"

    Article Title: Metanephric stromal tumor with BRAF V600E mutation in an adult patient: Case report and literature review

    Journal: Frontiers in Oncology

    doi: 10.3389/fonc.2022.993414

    Imaging features of adult metanephric stromal tumor with BRAF V600E mutation. (A) Computed tomography scan shows a slightly enhanced, well-defined, oval mass (white arrow), in the upper pole of the left kidney. (B) Magnetic resonance imaging demonstrates that the mass has low-signal intensity on T2-wighted imaging (white arrow).
    Figure Legend Snippet: Imaging features of adult metanephric stromal tumor with BRAF V600E mutation. (A) Computed tomography scan shows a slightly enhanced, well-defined, oval mass (white arrow), in the upper pole of the left kidney. (B) Magnetic resonance imaging demonstrates that the mass has low-signal intensity on T2-wighted imaging (white arrow).

    Techniques Used: Imaging, Mutagenesis, Computed Tomography, Magnetic Resonance Imaging

    Histological characteristics of adult metanephric stromal tumor with BRAF V600E mutation. (A) At low power, the tumor is non-encapsulated and has an overall expansile contour. H&E×15. (B) Subtly infiltrative border of the tumor with adjacent normal renal parenchyma (arrows). H&E×40. (C) Numerous entrapped native renal tubules are noted. H&E×100. (D) The tumor is composed of bland, spindle- or stellate-shaped cells, set in a predominantly collagenous and focally myxoid stroma. H&E×100. (E) The highly hyalinized stroma encircles and entraps native renal tubules (arrows). H&E×300. (F) The tumor induces angiodysplasia within entrapped blood vessels (arrow). H&E×300.
    Figure Legend Snippet: Histological characteristics of adult metanephric stromal tumor with BRAF V600E mutation. (A) At low power, the tumor is non-encapsulated and has an overall expansile contour. H&E×15. (B) Subtly infiltrative border of the tumor with adjacent normal renal parenchyma (arrows). H&E×40. (C) Numerous entrapped native renal tubules are noted. H&E×100. (D) The tumor is composed of bland, spindle- or stellate-shaped cells, set in a predominantly collagenous and focally myxoid stroma. H&E×100. (E) The highly hyalinized stroma encircles and entraps native renal tubules (arrows). H&E×300. (F) The tumor induces angiodysplasia within entrapped blood vessels (arrow). H&E×300.

    Techniques Used: Mutagenesis

    Immunohistochemistry of adult metanephric stromal tumor with BRAF V600E mutation. The tumor cells are diffusely and strongly positive for CD34. ×100.
    Figure Legend Snippet: Immunohistochemistry of adult metanephric stromal tumor with BRAF V600E mutation. The tumor cells are diffusely and strongly positive for CD34. ×100.

    Techniques Used: Immunohistochemistry, Mutagenesis

    Fluorescence in-situ hybridization analysis is negative for rearrangements of both the (A) EWSR1 (×1500, arrows indicate fused green and orange signals) and (B) FUS (×2000, arrows indicate fused green and orange signals) loci (Insets in A and B indicate schematic diagram of break-apart probes flanking EWSR1 and FUS , respectively). (C) Targeted next-generation sequencing discloses the pathogenic mutation of BRAF exon15: c.1799T>A (p.V600E) in the tumor, as illustrated by the Integrative Genomics Viewer screenshot.
    Figure Legend Snippet: Fluorescence in-situ hybridization analysis is negative for rearrangements of both the (A) EWSR1 (×1500, arrows indicate fused green and orange signals) and (B) FUS (×2000, arrows indicate fused green and orange signals) loci (Insets in A and B indicate schematic diagram of break-apart probes flanking EWSR1 and FUS , respectively). (C) Targeted next-generation sequencing discloses the pathogenic mutation of BRAF exon15: c.1799T>A (p.V600E) in the tumor, as illustrated by the Integrative Genomics Viewer screenshot.

    Techniques Used: Fluorescence, In Situ Hybridization, Next-Generation Sequencing, Mutagenesis



    Similar Products

    braf exon15 c 1799t a p v600e  (Geneseeq Technology Inc)
    86
    Geneseeq Technology Inc braf exon15 c 1799t a p v600e
    Imaging features of adult metanephric stromal tumor with BRAF <t>V600E</t> mutation. (A) Computed tomography scan shows a slightly enhanced, well-defined, oval mass (white arrow), in the upper pole of the left kidney. (B) Magnetic resonance imaging demonstrates that the mass has low-signal intensity on T2-wighted imaging (white arrow).
    Braf Exon15 C 1799t A P V600e, supplied by Geneseeq Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/braf exon15 c 1799t a p v600e/product/Geneseeq Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    braf exon15 c 1799t a p v600e - by Bioz Stars, 2025-01
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Imaging features of adult metanephric stromal tumor with BRAF V600E mutation. (A) Computed tomography scan shows a slightly enhanced, well-defined, oval mass (white arrow), in the upper pole of the left kidney. (B) Magnetic resonance imaging demonstrates that the mass has low-signal intensity on T2-wighted imaging (white arrow).

    Journal: Frontiers in Oncology

    Article Title: Metanephric stromal tumor with BRAF V600E mutation in an adult patient: Case report and literature review

    doi: 10.3389/fonc.2022.993414

    Figure Lengend Snippet: Imaging features of adult metanephric stromal tumor with BRAF V600E mutation. (A) Computed tomography scan shows a slightly enhanced, well-defined, oval mass (white arrow), in the upper pole of the left kidney. (B) Magnetic resonance imaging demonstrates that the mass has low-signal intensity on T2-wighted imaging (white arrow).

    Article Snippet: Genetic testing using targeted next-generation sequencing for 425 cancer-relevant genes (GENESEEQ PRIME) disclosed the pathogenic mutation of BRAF exon15: c.1799T>A (p.V600E) in the tumor ( ).

    Techniques: Imaging, Mutagenesis, Computed Tomography, Magnetic Resonance Imaging

    Histological characteristics of adult metanephric stromal tumor with BRAF V600E mutation. (A) At low power, the tumor is non-encapsulated and has an overall expansile contour. H&E×15. (B) Subtly infiltrative border of the tumor with adjacent normal renal parenchyma (arrows). H&E×40. (C) Numerous entrapped native renal tubules are noted. H&E×100. (D) The tumor is composed of bland, spindle- or stellate-shaped cells, set in a predominantly collagenous and focally myxoid stroma. H&E×100. (E) The highly hyalinized stroma encircles and entraps native renal tubules (arrows). H&E×300. (F) The tumor induces angiodysplasia within entrapped blood vessels (arrow). H&E×300.

    Journal: Frontiers in Oncology

    Article Title: Metanephric stromal tumor with BRAF V600E mutation in an adult patient: Case report and literature review

    doi: 10.3389/fonc.2022.993414

    Figure Lengend Snippet: Histological characteristics of adult metanephric stromal tumor with BRAF V600E mutation. (A) At low power, the tumor is non-encapsulated and has an overall expansile contour. H&E×15. (B) Subtly infiltrative border of the tumor with adjacent normal renal parenchyma (arrows). H&E×40. (C) Numerous entrapped native renal tubules are noted. H&E×100. (D) The tumor is composed of bland, spindle- or stellate-shaped cells, set in a predominantly collagenous and focally myxoid stroma. H&E×100. (E) The highly hyalinized stroma encircles and entraps native renal tubules (arrows). H&E×300. (F) The tumor induces angiodysplasia within entrapped blood vessels (arrow). H&E×300.

    Article Snippet: Genetic testing using targeted next-generation sequencing for 425 cancer-relevant genes (GENESEEQ PRIME) disclosed the pathogenic mutation of BRAF exon15: c.1799T>A (p.V600E) in the tumor ( ).

    Techniques: Mutagenesis

    Immunohistochemistry of adult metanephric stromal tumor with BRAF V600E mutation. The tumor cells are diffusely and strongly positive for CD34. ×100.

    Journal: Frontiers in Oncology

    Article Title: Metanephric stromal tumor with BRAF V600E mutation in an adult patient: Case report and literature review

    doi: 10.3389/fonc.2022.993414

    Figure Lengend Snippet: Immunohistochemistry of adult metanephric stromal tumor with BRAF V600E mutation. The tumor cells are diffusely and strongly positive for CD34. ×100.

    Article Snippet: Genetic testing using targeted next-generation sequencing for 425 cancer-relevant genes (GENESEEQ PRIME) disclosed the pathogenic mutation of BRAF exon15: c.1799T>A (p.V600E) in the tumor ( ).

    Techniques: Immunohistochemistry, Mutagenesis

    Fluorescence in-situ hybridization analysis is negative for rearrangements of both the (A) EWSR1 (×1500, arrows indicate fused green and orange signals) and (B) FUS (×2000, arrows indicate fused green and orange signals) loci (Insets in A and B indicate schematic diagram of break-apart probes flanking EWSR1 and FUS , respectively). (C) Targeted next-generation sequencing discloses the pathogenic mutation of BRAF exon15: c.1799T>A (p.V600E) in the tumor, as illustrated by the Integrative Genomics Viewer screenshot.

    Journal: Frontiers in Oncology

    Article Title: Metanephric stromal tumor with BRAF V600E mutation in an adult patient: Case report and literature review

    doi: 10.3389/fonc.2022.993414

    Figure Lengend Snippet: Fluorescence in-situ hybridization analysis is negative for rearrangements of both the (A) EWSR1 (×1500, arrows indicate fused green and orange signals) and (B) FUS (×2000, arrows indicate fused green and orange signals) loci (Insets in A and B indicate schematic diagram of break-apart probes flanking EWSR1 and FUS , respectively). (C) Targeted next-generation sequencing discloses the pathogenic mutation of BRAF exon15: c.1799T>A (p.V600E) in the tumor, as illustrated by the Integrative Genomics Viewer screenshot.

    Article Snippet: Genetic testing using targeted next-generation sequencing for 425 cancer-relevant genes (GENESEEQ PRIME) disclosed the pathogenic mutation of BRAF exon15: c.1799T>A (p.V600E) in the tumor ( ).

    Techniques: Fluorescence, In Situ Hybridization, Next-Generation Sequencing, Mutagenesis